Member Info for Let-It-Roll

Apparently Vlad retweeted it tonight and then deleted it. Eli Lilly coukd easily be the anonymous 'Global Co'. It is possible the 3 month delay could end in a buyout.

Woodcot. You are so wrong on your assessment of me. I originally bought in at 3.8 Had 1.5m and road the spike to 15p. Sold some. And have been buying since 8p on the way down. Hence the rise in my average to 5.81. You can believe what you want, but some here are members with myself of another group and they will substantiate. :-)

Sounds like he's getting hassled

Worth posting that list out on the twittersphere Quickdraw

Couldn't agree more. I fully expect this share to be at 40p+ by September once everything comes together and imo that is all within the next 75 days.

It's not a success yet. Still a bit squeaky bum time.

This share will either be the best or worst decision I've made lol.

Thanks! 2.5m now av. 5.8

Sorry. Mis type. 6 x 50k

Mr 4 x 50k was me. Sold my IPF at a tiny profit and added here.

I'll keep my gob shut in future lol

7p+ spike to 8p maybe. Depends what financials/revenue are mentioned if any. Could be anyones guess then.

Current average is 5.9

I hold 2.1m will either be my best or worse ever decision.

Messaged Vlad asking where the RNS was from Hemo regarding the Orgenesis news. Hemo replied with 2 x thumbs up.

Have just posted the images up on Twitter under the #Hemo hashtag.

Make of it what you will.

Distressed seller hopefully finished selling. One of our placement buyers additionally loading up imo. £176k is a lot of money.

Could he really remain CEO of Biopharma Solutions yet be a Business Development Advisor for Hemo. I would have thought that would be a conflict of interest?

Given his history and seniority. Perhaps it would warrant an RNS?

Sorry: I meant Manhattan Biosolutions. Not pharma.

Anyone know if Dr Boris Shor is a new addition to the Hemo team? I can't find any google reference for his appointment in a non exec/advisory role or otherwise. Appears that he was CEO of Manhatttan Biopharma in May 2020

Hmmm. Interesting :-)